Release
Date: 1/23/2023
Expiration
Date:1/23/2024
Activity Overview
This activity will review new developments for clinical treating patients with GA.
Target Audience
This activity is intended for retina specialists, ophthalmologists, and other members of the healthcare team who treat patients with geographic atrophy (GA).
Learning Objectives
Upon completion of the educational activity, participants should be able to:
- Describe the use of artificial intelligence-supported spectral-domain optical coherence tomography in monitoring GA progression in patients treated with a complement C3 inhibitor.
Criteria for Success
To obtain a certificate of completion, a score of 70% or better on the post-test is required. Please proceed with the activity until you have successfully completed this program, answered all test questions, completed the post-test and evaluation, and have received a digital copy of your certificate. You must participate in the entire activity to receive credit. There is no fee to participate in this activity. If you have questions about this activity, please contact AKH Inc. at
ketrea@akhcme.com
CE credit provided by AKH Inc., Advancing Knowledge in Healthcare
In support of improving patient care, this activity has been planned and implemented by AKH Inc., Advancing Knowledge in Healthcare and International Healthcare Media, LLC. AKH Inc., Advancing Knowledge in Healthcare is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Physicians
AKH Inc., Advancing Knowledge in Healthcare designated this enduring material for a maximum of 0.25
AMA PRA Category 1 Credit(s). Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Commercial Support
There is no commercial support for this activity.
|
Name
|
Relationship
|
Commercial Interest
|
|
Christina T. Loguidice
|
N/A
|
Nothing to disclose
|
Urasula Schmidt-Erfurth,
MD (Faculty)
|
Consultant/Advisor,
Research Funding
|
Apellis
|
|
Research Funding
|
Genentech, Kodiak, Novartis
|
Patent Beneficiary,
Stocks, Research Funding
|
RetinSight
|
Dorothy Caputo, MA, BSN,
RN, Senior Director of
Continuing Education &
Compliance
|
N/A
|
Nothing to disclose
|
Michele Bielarski, RN
(planner/reviewer)
|
N/A
|
Nothing to disclose
|
|
AKH Inc Staff and Planners
|
N/A
|
Nothing to disclose
|
International Healthcare
Media, LLC Staff and
Planners
|
N/A
|
Nothing to disclose
|
|
All of the relevant financial relationships listed for these individuals have been mitigated.
|
Disclosures
It is the policy of AKH Inc. to ensure independence, balance, objectivity, scientific rigor, and integrity in all of its continuing education activities. The author must disclose to the participants any significant relationships with ineligible companies whose products or devices may be mentioned in the activity or with the commercial supporter of this continuing education activity. Identified conflicts of interest are mitigated by AKH prior to accreditation of the activity. AKH planner and reviewers have no relevant financial relationships to disclose.
Disclosure of Unlabeled Use and Investigational Product
This educational activity may include discussion of uses of agents that are investigational and/or unapproved by the FDA. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Disclaimer
This course is designed solely to provide the healthcare professional with information to assist in his/her practice and professional development and is not to be considered a diagnostic tool to replace professional advice or treatment. The course serves as a general guide to healthcare professional, and therefore, cannot be considered as giving legal, nursing, medical, or other professional advice in specific cases. AKH Inc. specifically disclaim responsibility for any adverse consequences resulting directly or indirectly from information in the course, for undetected error, or through participant's misunderstanding of the content.